Global Impact - The importance of the Irish biopharma industry

The report highlights how the pandemic, geopolitical tensions, and heightened international competition are emphasising a renewed focus on competitiveness. The sector has identified policy priorities across four key areas:

  1. Achieving sustainability goals through strengthening financial, regulatory, and advisory supports.
  2. Encouraging and resourcing innovation and broadening the ecosystem supported by an “Office of LifeSciences.”
  3. Meeting skills demand through effective implementation of the recommendations of the Expert Group on Future Skills Needs for BioPharma.
  4. Remaining competitive through fit-for-purpose regulation.